AstraZeneca Profit Sags as Coronavirus Slows Diagnoses

Bookmark
(Bloomberg) -- AstraZeneca Plc’s third-quarter profit fell short of analysts’ estimates as the pandemic inflated costs and discouraged some doctors’ visits and diagnoses.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.